Novelion Therapeutics Inc. (NVLN) Fell -5.06% or -0.17 To Price $3.19 On Wednesday


Novelion Therapeutics Inc. (NVLN) fell -5.06% or -0.17 to $3.19. It is approximately 48443 shares traded, which is 133.79% compare to the average total volume 36207. The market cap of NVLN is $59.20 million. The year to date change is 0.9%. The 52 week price range is from $3.08 to $10.86. Price of NVLN have changed 1.20% during last week. It have changed -24.32% over last month, -11.58% over last 3 months, -52.88% over last 6 months and -68.69% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVLN is 4.30. It is 34.80% above current price. The 200-day Moving Averages for NVLN is 5.93. It is 85.89% above current price. The 52-week High is 10.86. It is 240.44% from the current price. The 52-week Low is 3.08. It is -3.45% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NVLN is 85.87 on 2018-03-15. Short % to float is 11.78%. There are some statistics of NVLN. It is has market cap $59.20 million. The share outstanding is 18.56 million. The average volume is 36207. The revenue is 99.53M. The gross profit is 39.30M. The percent of top 15 Institution holding is 82.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVLN is -168.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVLN is -29.81%.


Tags:

Share this post